Current and future therapeutic options for irritable bowel syndrome with diarrhea and functional diarrhea
G Piovezani Ramos, M Camilleri - Digestive diseases and sciences, 2023 - Springer
Irritable bowel syndrome with diarrhea and functional diarrhea are disorders of gut-brain
interaction presenting with chronic diarrhea; they have significant impact on quality of life …
interaction presenting with chronic diarrhea; they have significant impact on quality of life …
Chinese herbal medicine for irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials
H Zheng, S Jin, YL Shen, WY Peng, K Ye… - Frontiers in …, 2021 - frontiersin.org
Purpose: Chinese herbal medicine (CHM) is an important complementary and alternative
therapy for the management of irritable bowel syndrome (IBS). Previous meta-analyses …
therapy for the management of irritable bowel syndrome (IBS). Previous meta-analyses …
Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable …
J Sun, M Zhang, W Liu, Y Liu, D Zhang, X Fan… - Frontiers in …, 2023 - frontiersin.org
Introduction The Chang-Kang-Fang (CKF) formula, a traditional Chinese herbal formula, can
decrease serotonin (5-HT) levels and treat irritable bowel syndrome (IBS). Probiotics have a …
decrease serotonin (5-HT) levels and treat irritable bowel syndrome (IBS). Probiotics have a …
[HTML][HTML] Atractylodes macrocephala-Paeonia lactiflora Class Formula for the Treatment of Irritable Bowel Syndrome: A Systematic Review With Meta-Analysis and Trial …
W Bai, Z Wang, J Liang, H Deng - Cureus, 2023 - ncbi.nlm.nih.gov
Previous meta-analyses suggested that Chinese herbal medicine (CHM) is effective for
irritable bowel syndrome (IBS). Formulas with Atractylodes macrocephala and Paeonia …
irritable bowel syndrome (IBS). Formulas with Atractylodes macrocephala and Paeonia …
How fragile the positive results of Chinese herbal medicine randomized controlled trials on irritable bowel syndrome are?
M Luo, J Huang, Y Wang, Y Li, Z Liu, M Liu… - … Medicine and Therapies, 2024 - Springer
Objective The fragility index (FI), which is the minimum number of changes in status from
“event” to “non-event” resulting in a loss of statistical significance, serves as a significant …
“event” to “non-event” resulting in a loss of statistical significance, serves as a significant …
[HTML][HTML] Using PRECIS-2 in Chinese herbal medicine randomized controlled trials for irritable bowel syndrome: A methodological exploration based on literature
M Luo, Y Wang, J Huang, Y Li, W Li, H Li, Z Liu… - Integrative Medicine …, 2024 - Elsevier
Background The pragmatism levels of randomized controlled trials (RCTs) mean how similar
the interventions delivered in the trial setting match those in the setting where the results will …
the interventions delivered in the trial setting match those in the setting where the results will …
[PDF][PDF] 健脾安肠汤联合匹维溴胺治疗肠易激综合征的临床疗效及对血清5-HT, CGRP, SP, VIP 水平的影响
王思玉， 彭美哲， 李享， 邓晋妹， 王帅… - 现代生物医学 …, 2019 - biomed.cnjournals.com
摘要目的: 探讨健脾安肠汤联合匹维溴胺治疗肠易激综合征的临床疗效及对血清5-羟色胺(5-HT),
降钙素基因相关肽(CGRP), 结肠黏膜P 物质(SP), 血管活性肠态(VIP) 水平的影响. 方法 …
降钙素基因相关肽(CGRP), 结肠黏膜P 物质(SP), 血管活性肠态(VIP) 水平的影响. 方法 …
Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta‐analysis
M Chen, D Qin, SL Huang, TC Tang… - Neurogastroenterology …, 2021 - Wiley Online Library
Background Chinese herbal medicine (CHM) is gaining popularity in treating irritable bowel
syndrome (IBS). Although its efficacy was shown in recent randomized controlled trials …
syndrome (IBS). Although its efficacy was shown in recent randomized controlled trials …
《 脾虚证中医诊疗专家共识(2023)》 解读
胡玲， 唐旭东 - 中国中西医结合消化杂志, 2024 - whuhzzs.com
《 脾虚证中医诊疗专家共识(2023)》 是2020 年11 月由中华中医药学会脾胃病分会在北京主导,
联合全国50 余家三级甲等医院, 高等院校及科研机构共同修订并最终由国内权威期刊 …
联合全国50 余家三级甲等医院, 高等院校及科研机构共同修订并最终由国内权威期刊 …
[PDF][PDF] 肠安Ⅰ 号方对肝郁脾虚型腹泻型肠易激综合征模型大鼠内脏高敏感的影响
马祥雪， 吕林， 杨斌， 王凤云， 唐旭东 - 中国中西医结合杂志, 2021 - cjim.cn
摘要目的探讨肠安Ⅰ 号方对肝郁脾虚型腹泻型肠易激综合征(IBS-D) 模型大鼠内脏敏感性的
调节作用, 及其对腰骶段背根神经节P 物质(SP), 降钙素基因相关肽(CGRP), 蛋白酶激活受体-2 …
调节作用, 及其对腰骶段背根神经节P 物质(SP), 降钙素基因相关肽(CGRP), 蛋白酶激活受体-2 …